Literature DB >> 29508753

Neoadjuvant chemotherapy for early breast cancer.

Petros Charalampoudis1, Andreas Karakatsanis2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29508753     DOI： 10.1016/S1470-2045(18)30115-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer.

Authors:  Chao Ni; Yimin Shen; Qingqing Fang; Min Zhang; Hongjun Yuan; Jingxia Zhang; Miaochun Zhong; Yajuan Zheng
Journal:  Cancer Med       Date:  2020-02-04       Impact factor: 4.452

2.  Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.

Authors:  Guoyu Mu; Hong Ji; Hui He; Hongjiang Wang
Journal:  Breast Cancer       Date:  2020-11-27       Impact factor: 4.239
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.